GALECTIN THERAPEUTICS INC — Director's Dealing 2017

Dec 8, 2017

SEC Form 4/A — Form 4/A

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2017-12-08

Reporting Person: Rubin Marc (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-08	Common Stock	P	7000	$1.8531	Acquired	55581	Direct

Footnotes

F1: The footnote on the original Form 4, filed on December 8, 2017, incorrectly indicated that the shares were sold, instead of purchased, in multiple transactions. The shares were purchased in multiple transactions at prices ranging from $1.819 to $1.92. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.